Premium
Management of the renal adverse effects of lithium: an audit cycle
Author(s) -
Gupta Sumeet,
Das Sudipta,
Khastgir Udyan,
Wai San Ip Victoria,
Suwito Cindy
Publication year - 2019
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.534
Subject(s) - lithium (medication) , adverse effect , audit , medicine , intensive care medicine , bipolar disorder , depression (economics) , clinical practice , psychiatry , family medicine , business , accounting , economics , macroeconomics
Lithium is a standard first‐line treatment for bipolar disorder and one of the recommended augmenting agents for treatment‐resistant depression. However, concerns remain about the long‐term organ toxicity of this drug, mainly renal adverse effects. Here, Dr Gupta and colleagues discuss their local audit of administering lithium in CKD patients and how the results were used to inform trust policy and improve clinical practice.